Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Cyclizine
Amdipharm Limited
R06AE; R06AE03
Cyclizine
50/1 Base mg/ml
Solution for injection
Product subject to prescription which may not be renewed (A)
Piperazine derivatives; cyclizine
Marketed
1979-04-01
PACKAGE LEAFLET: INFORMATION FOR THE USER VALOID ® 50 MG/1 ML SOLUTION FOR INJECTION (Cyclizine lactate) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or nurse. If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4. The name of your medicine is Valoid 50 mg/1 ml Solution for Injection. It will be referred to Valoid Injection for ease hereafter. WHAT IS IN THIS LEAFLET 1. What Valoid Injection is and what it is used for 2. What you need to know before you are given Valoid Injection 3. How Valoid Injection will be given to you 4. Possible side effects 5. How to store Valoid Injection 6. Contents of the pack and other information 1. WHAT VALOID INJECTION IS AND WHAT IT IS USED FOR Each 1 ml injection ampoule contains 50 mg of the active ingredient, cyclizine lactate. Valoid Injection belongs to a group of medicines called antihistamines. It is used in adults to block the effects of substances called histamine and acetylcholine in your body, which can make you feel sick (nausea) or actually vomit. Valoid Injection is used for travel or motion sickness, and nausea which can be caused by radiotherapy of some medicines. Some ear disorders, for example Menière’s disease, can cause loss of balance. Valoid Injection is used to treat the dizziness and vomiting which can come with this. Valoid injection is used to prevent and treat nausea and vomiting caused by certain painkillers (narcotic analgesics) and general anaesthetics following surgery. Valoid Injection may be given before emergency surgery to stop this happening during the operation. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN VALOID INJECTION DO NOT USE VALOID INJECTION IF YOU: are allergic to cyclizine lactate or any of the other ingredients of this medicine (listed in section 6). Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Valoid 50 mg/ml Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 ml ampoule contains 50mg cyclizine lactate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for Injection Clear, colourless solution for injection. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Valoid is indicated in adults for the prevention and treatment of nausea and vomiting, including:- Motion sickness, when the oral route cannot be used. Nausea and vomiting caused by narcotic analgesics and by general anaesthetics in the post-operative period. Vomiting associated with radiotherapy, especially for breast cancer since cyclizine does not elevate prolactin levels. Valoid Injection, by the intravenous route, is also indicated pre-operatively in patients undergoing emergency surgery in order to reduce the hazard of regurgitation and aspiration of gastric content during induction of general anaesthesia. Valoid may be of value in relieving vomiting and attacks of vertigo associated with Menière's disease and other forms of vestibular disturbance when the oral route cannot be used. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For the prevention of postoperative nausea and vomiting, administer the first dose by slow intravenous injection 20 minutes before the anticipated end of surgery. Adults 50 mg intramuscularly or intravenously up to three times daily. When used intravenously, Valoid Injection should be injected slowly into the bloodstream, with only minimal withdrawal of blood into the syringe. Cyclizine given intravenously, in half the recommended dose, increases the lower oesophageal sphincter tone and thereby reduces the hazard of regurgitation and aspiration of gastric contents if given to patients, undergoing emergency surgery, before induction of general anaesthesia. Posology H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ __ Read the complete document